With EU Unitary Patent Sealed, All Eyes Are On New Patent Court
This article was originally published in Scrip
Executive Summary
The final step in creating a unitary patent system in Europe has been taken with the completion of a legal framework containing the implementing and financial rules for the new patent as well as the rules governing the level of renewal fees and the distribution of the fees among the European Patent Office and the participating member states.
You may also be interested in...
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.
UK Industry Gets More Time To Adapt To Post-Brexit Import Rules
The BioIndustry Association has welcomed a decision to delay the deadline for compliance with new regulations on the classification of imported materials used in drug production, but says the border rules are still not proportionate for life science products.
Industry Calls On G20 To Boost Regulatory Harmonization & Tackle AMR
Robust regulatory systems with effective approval pathways and surveillance mechanisms to ensure continuity in clinical research, manufacturing and supply are needed to prepare for current and future health threats, says industry.